BNP Paribas Financial Markets’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$20.5K	Sell	3,045 -5,189	-63%	-$34.9K	﹤0.01%	3780
2025 Q1	$74.4K	Buy	8,234 +4,910	+148%	+$44.4K	﹤0.01%	3318
2024 Q4	$57.5K	Buy	+3,324	New	+$57.5K	﹤0.01%	3527
2022 Q4	–	Sell	-198	Closed	-$3.12K	–	3877
2022 Q3	$3.12K	Buy	+198	New	+$3.12K	﹤0.01%	3583